Dräger Overview
- Year Founded
-
1889
- Status
-
Public
- Employees
-
16,682
- Stock Symbol
-
DRW8
- Investments
-
13
- Share Price
-
$93.70
- (As of Friday Closing)
Dräger General Information
Description
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical division and safety division. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management.
Contact Information
Website
www.draeger.comCorporate Office
- Moislinger Allee 53-55
- 23558 Lubeck
- Germany
Corporate Office
- Moislinger Allee 53-55
- 23558 Lubeck
- Germany
Dräger Stock Performance
As of 13-Nov-2026, Dräger’s stock price is $93.70. Its current market cap is $2.02B with 18.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $93.70 | $92.09 | $65.33 - $109.22 | $2.02B | 18.8M | 3.87K | $10.48 |
Dräger Financials Summary
As of 30-Sep-2026, Dräger has a trailing 12-month revenue of $4.17B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,422,386 | 1,461,488 | 940,467 | 1,171,186 |
| Revenue | 4,173,772 | 3,927,602 | 3,647,625 | 3,650,386 |
| EBITDA | 322,681 | 439,443 | 376,631 | 347,255 |
| Net Income | 197,044 | 157,353 | 134,622 | 119,497 |
| Total Assets | 3,700,045 | 3,715,427 | 3,218,942 | 3,420,714 |
| Total Debt | 259,610 | 475,846 | 411,629 | 521,067 |
Dräger Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dräger Comparisons
Industry
Financing
Details
Dräger Competitors (27)
One of Dräger’s 27 competitors is Hill-Rom, a Corporation company based in Essen, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hill-Rom | Corporation | Essen, Germany | ||||
| Steris | Formerly PE-Backed | Mentor, OH | ||||
| Medline Produtos Médicos e Hospitalares | Corporation | Sao Paulo, Brazil | ||||
| Hill-Rom Holdings | Corporate Backed or Acquired | Deerfield, IL | ||||
| Avanos Medical | Private Equity-Backed | Alpharetta, GA |
Dräger Patents
Dräger Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4838441-A1 | Dispensing machine for gas measuring devices and method for dispensing and method for returning a gas measuring device | Pending | 20-Apr-2026 | ||
| GB-202510774-D0 | Pressure relief valve | Pending | 03-Jul-2025 | ||
| GB-202509266-D0 | Adapter | Pending | 12-Jun-2025 | ||
| GB-202509133-D0 | Support system | Pending | 10-Jun-2025 | ||
| DE-102025117788-A1 | Dispensing machine for gas measuring devices, as well as procedures for dispensing and returning a gas measuring device | Pending | 08-May-2025 |
Dräger Signals
Dräger Investments & Acquisitions (13)
Dräger’s most recent deal was a Later Stage VC with Sibel Health for . The deal was made on 30-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sibel Health | 30-Sep-2025 | Later Stage VC | Monitoring Equipment | ||
| Kuva Systems | 25-Jan-2023 | Later Stage VC | Other Hardware | ||
| Sibel Health | 04-Aug-2022 | Later Stage VC | Monitoring Equipment | ||
| Sibel Health | 08-Jul-2022 | Later Stage VC | Monitoring Equipment | ||
| Hypros | 27-Jan-2022 | Later Stage VC | Other Healthcare Technology Systems |
Dräger ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Dräger Exits (3)
Dräger’s most recent exit was on 25-Jan-2023 from Kuva Systems. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Kuva Systems | 25-Jan-2023 | Completed |
|
||
| Stimit | 01-Apr-2021 | Completed |
|
||
| Kuva Systems | 17-Jun-2020 | Seed Round | Completed |
|
Dräger Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Fundus Grundstucksverwaltung | Lubeck, Germany | 2013 | |
| GasSecure | Oslo, Norway | 2008 | |
| Dräger Medical Ansy | Lubeck, Germany | 2003 | |
| Drager Ireland | Dublin, Ireland | 2002 | |
| Mapra Assekuranzkontor | Lubeck, Germany | 1981 |
Dräger FAQs
-
When was Dräger founded?
Dräger was founded in 1889.
-
Where is Dräger headquartered?
Dräger is headquartered in Lubeck, Germany.
-
What is the size of Dräger?
Dräger has 16,682 total employees.
-
What industry is Dräger in?
Dräger’s primary industry is Medical Supplies.
-
Is Dräger a private or public company?
Dräger is a Public company.
-
What is Dräger’s stock symbol?
The ticker symbol for Dräger is DRW8.
-
What is the current stock price of Dräger?
As of 13-Nov-2026 the stock price of Dräger is $93.70.
-
What is the current market cap of Dräger?
The current market capitalization of Dräger is $2.02B.
-
What is Dräger’s current revenue?
The trailing twelve month revenue for Dräger is $4.17B.
-
Who are Dräger’s competitors?
Hill-Rom, Steris, Medline Produtos Médicos e Hospitalares, Hill-Rom Holdings, and Avanos Medical are some of the 27 competitors of Dräger.
-
What is Dräger’s annual earnings per share (EPS)?
Dräger’s EPS for 12 months was $10.48.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process